April 2013 – The CenterWatch Monthly : Print
20 Innovators Changing the Face of the Clinical Trials Industry
Marking CenterWatch’s 20th anniversary of its flagship publication The CenterWatch Monthly, we are publishing a special commemorative issue focusing on 20 innovators disrupting and transforming the drug development paradigm.
Although the industry is notoriously resistant to change, forward-thinking leaders realize they must explore new approaches in order to transform drug development and revitalize the industry. Many of the new approaches involve collaboration, which can be more efficient, quicker and can achieve better outcomes than R&D centered in pharmaceutical companies.
“From collaboration to crowdsourcing to consolidation, these innovations and the people behind them truly are making a difference,” said Joan Chambers, chief operating officer of CenterWatch. “At every phase of development—from early R&D to study conduct to post-approval—innovators share a common vision: to engage patients and other stakeholders as partners in the process to deliver new treatments to patients more quickly, safely and efficiently...”
Also in this issue:
- Implications of FDA draft guidance: Assessing investigator qualifications
- Is your study in need of a rescue?
- Regulatory Update
- Month in Review
- FDA Actions
- Study Lead Opportunities
- New Drugs in the Pipeline